➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Baxter
McKesson
Express Scripts
Colorcon

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Isoquinoline

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Isoquinoline?

Isoquinoline is an investigational drug.

There have been 12 clinical trials for Isoquinoline. The most recent clinical trial was a Phase 1 trial, which was initiated on October 22nd 2020.

The most common disease conditions in clinical trials are Cysticercosis, HIV Infections, and Taeniasis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), Tianjin Anding Hospital, and xiaohua li.

There are three US patents protecting this investigational drug and thirty-nine international patents.

Recent Clinical Trials for Isoquinoline
TitleSponsorPhase
Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With HypertensionJun TaoPhase 4
Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia PatientsTianjin Anding HospitalPhase 4
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail ApproachNational Center for Complementary and Integrative Health (NCCIH)Early Phase 1

See all Isoquinoline clinical trials

Clinical Trial Summary for Isoquinoline

Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline

See all Isoquinoline clinical trials

US Patents for Isoquinoline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isoquinoline   Get Started for $10 Materials for organic electroluminescent devices Merck Patent GmbH (DE)   Get Started for $10
Isoquinoline   Get Started for $10 Compositions and methods for treating Dengue virus infection The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA)   Get Started for $10
Isoquinoline   Get Started for $10 Quinazolinone and isoquinolinone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (Tokyo, JP)   Get Started for $10
Isoquinoline   Get Started for $10 Polyurethane fiber TORAY OPELONTEX CO., LTD. (Osaka, JP)   Get Started for $10
Isoquinoline   Get Started for $10 Materials for organic light emitting diode UNIVERSAL DISPLAY CORPORATION (Ewing, NJ)   Get Started for $10
Isoquinoline   Get Started for $10 Platinum(II) complexes for OLED applications VERSITECH LIMITED (Hong Kong, CN)   Get Started for $10
Isoquinoline   Get Started for $10 Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid L'OREAL (Paris, FR)   Get Started for $10
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Isoquinoline

Drugname Country Document Number Estimated Expiration Related US Patent
Isoquinoline China CN105916963 2034-01-17   Get Started for $10
Isoquinoline European Patent Office EP3094703 2034-01-17   Get Started for $10
Isoquinoline Japan JP2017508728 2034-01-17   Get Started for $10
Isoquinoline South Korea KR20160103144 2034-01-17   Get Started for $10
Isoquinoline World Intellectual Property Organization (WIPO) WO2015106789 2034-01-17   Get Started for $10
Isoquinoline European Patent Office EP3166637 2034-07-10   Get Started for $10
Isoquinoline World Intellectual Property Organization (WIPO) WO2016007540 2034-07-10   Get Started for $10
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.